Thompson Elizabeth H.Z.
EVP, Head of Research & Dev at ACAD; EVP, Research & Development at HORIZON PHARMA, INC.
- Sold, on record
- $2.8M
- Dollars the filings state
- Form 4 sales
- 6
- Latest Jul 30, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- ACADACADIA PHARMACEUTICALS INCEVP, Head of Research & Dev
- HORIZON PHARMA, INC.EVP, Research & Development
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- HORIZON PHARMA, INC.21,729 shares
- ACAD19,993 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale HORIZON PHARMA, INC.UnusualAug 5, 2021 2021
Sold 7,542 shares at $106.34 ($802k)
Thompson Elizabeth H.Z., EVP, Research & Development
Sold 34.7% of holdings ($2.3M position)14,187 shares leftFirst sale on recordFiling
- 2 Form 4 sale HORIZON PHARMA, INC.UnusualApr 18, 2022 +256 days
Sold 8,098 shares at $115.64 ($936k)
Thompson Elizabeth H.Z., EVP, Research & Development
Sold 38.3% of holdings ($2.4M position)13,058 shares leftFiling
- 3 Form 4 sale HORIZON PHARMA, INC.Plan not statedJul 7, 2022 +80 days
Sold 82 shares at $85.01 ($7k)
Thompson Elizabeth H.Z., EVP, Research & Development
Sold 0.6% of holdings ($1.1M position)12,976 shares leftFiling
- 4 Form 4 sale HORIZON PHARMA, INC.UnusualJul 20, 2022 +13 days
Sold 6,007 shares at $85.00 ($511k)
Thompson Elizabeth H.Z., EVP, Research & Development
Sold 46.3% of holdings ($1.1M position)6,969 shares left0.8x usual sizeFiling
- 5 Form 4 sale ACADUnusualMar 25, 2026 +1344 days
Sold 3,435 shares at $21.47 ($74k)
Thompson Elizabeth H.Z., EVP, Head of Research & Dev
No 10b5-1 planSold 51.2% of holdings ($144k position)3,280 shares leftFirst sale on recordFiling
- 6 Form 4 sale ACADUnusualJul 30, 2026 +127 days
Sold 16,558 shares at $26.13 ($433k)
Thompson Elizabeth H.Z., EVP, Head of Research & Dev
No 10b5-1 planSold 46.6% of holdings ($929k position)18,994 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (6)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 30, 2026 | Jul 31, 2026 | ACAD | EVP, Head of Research & Dev | Form 4 sale | 16,558 | $433k | 46.6% | Unusual | SEC |
| Mar 25, 2026 | Mar 26, 2026 | ACAD | EVP, Head of Research & Dev | Form 4 sale | 3,435 | $74k | 51.2% | Unusual | SEC |
| Jul 20, 2022 | Jul 20, 2022 | HORIZON PHARMA, INC. | EVP, Research & Development | Form 4 sale | 6,007 | $511k | 46.3% | Unusual | SEC |
| Jul 7, 2022 | Jul 11, 2022 | HORIZON PHARMA, INC. | EVP, Research & Development | Form 4 sale | 82 | $7k | 0.6% | Plan not stated | SEC |
| Apr 18, 2022 | Apr 20, 2022 | HORIZON PHARMA, INC. | EVP, Research & Development | Form 4 sale | 8,098 | $936k | 38.3% | Unusual | SEC |
| Aug 5, 2021 | Aug 6, 2021 | HORIZON PHARMA, INC. | EVP, Research & Development | Form 4 sale | 7,542 | $802k | 34.7% | Unusual | SEC |